OR WAIT null SECS
March 20, 2019
Think ahead to production requirements when planning strategies in early development of gene and cell therapies.
The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.
March 12, 2019
The companies will join forces to improve gene- and cell-therapy manufacturing using the cloud and machine learning.
March 08, 2019
The new facility, located at the company’s headquarters in Pittsburgh, PA, is expected to meet all clinical and commercial development needs of the company’s lead gene therapy program.
March 02, 2019
While allogeneic therapies can use existing regulatory and quality frameworks, autologous treatments will require pharma’s adoption of true just-in-time and right-first-time concepts, says consultant James Blackwell.
February 21, 2019
Mustang intends to combine an oncolytic virus with an interleukin-13 Rα2-(IL13Rα2)-specific chimeric antigen receptor to potentially enhance efficacy in treating glioblastoma multiforme.
February 20, 2019
The company will invest an additional $60 million to expand its manufacturing facility in Durham County, NC.
February 15, 2019
The partnership will expand Lonza’s offering of hematopoietic cell lines.
February 01, 2019
The acquisition will boost Hitachi Chemical’s presence in the European regenerative medicines market.
Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases.